ROARABLE
FREE $100K
Today Screener Big Ideas Track Record 💰 $100K Arena 🎲 Predictions 🏛️ Insiders 8 Analysts
Stock Ratings / Health Care / LFST
OPCH (74) HIMS (60) CHE (83) AVAH (65) ⌘ Pro Terminal →

LifeStance Health Group Inc. (LFST) — RQD Stock Rating Cockpit

$13.26 -1.04% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $13.21

LifeStance Health Group Inc. (LFST) carries a Roarable Rating of C+ (Hold) with 67/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

ROARABLE C+ • HOLD / WATCH Cap $5.12B
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on LFST Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is LFST stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, LifeStance Health Group Inc. (NASDAQ: LFST) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 67/100 at a spot price of $13.26 (-1.04% 1D, market cap $5.12B). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 16/20, SEC Balance-Sheet Forensics 18/20, FRED Macro Regime Fit 13/20, and Executive Insider Alignment 10/20. Across 1015 tracked Health Care issuers, LFST ranks #104 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does LFST compare to OPCH and HIMS in the Health Care sector?
▼

Within the Health Care sector (Medical/Nursing Services), LFST carries a Roarable C+ (67/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of 1.2%. By comparison, OPCH (Option Care Health Inc.) holds a B grade (74/100 RQD, P/E 23.0x, ROIC 11.9%, cap $4.77B) and HIMS (Hims & Hers Health Inc.) posts a C- grade (60/100 RQD, P/E 53.9x, ROIC 8.4%, cap $6.46B). Among the 5-stock peer group, OPCH leads on earnings multiple (23.0x) while CHE leads on capital efficiency (23.4% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for LFST?
▼

Per LFST's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001845257), LifeStance Health Group Inc. generated $1.42B in revenue (+13.9% YoY), $9.7M in net income, and $110.0M in free cash flow against $2.20B in total assets and $265.9M in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $13.21 (-0.38%)🧬 Cannibal Buyback (-0.68% YoY Shares)⚙️ Cash Engine: 10/20 (D) • 7.7% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record: Scores of 67/100 (C+) historically posted market-perform odds over rolling 90-day windows (+1.6% avg 90D alpha vs SPY • 56.4% hit rate — wait for RQD ≥ 70 breakout).
Audit Bucket Track Record →
RQD QUANT TACHOMETERHOLD / WATCH • C+
025507510067
JEV AI Jury Split (Battleground)
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw C- · Rk B+
Cash (10)Whales (16)SEC (18)Macro (13)CEO (10)
Each axis scored 0–20
12M PRICE TARGET CONE+4.1% Base Target
$16 Bull$14 Base$11 Bear
📬 FREE LFST RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for LFST)Realized 20D OHLCV Swing Band: ±6.8%
Deterministic 5-Pillar Attribution (67/100 Composite)
🔍 WHY LFST SCORES 67/100 (C+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+18/20 pts (27% of score)

Altman Z-Score 4.84 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 8/9

▲ #2 Bullish Driver: Whale & Options Positioning+16/20 pts (24% of score)

20D Institutional Volume Accumulation (±6.8% realized swing band)

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution10/20 pts (-10 pt drag)

Cannibal Buyback (-0.68% YoY Shares) & executive Form 4 sales trim 10 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
59
Grade C$12.32-0.8% Next Q
Q2 (-2Q)
62
Grade C+$12.22+7.2% Next Q
Q3 (-1Q)
64
Grade C+$13.10+1.2% Next Q
Current
67
Grade C+$13.26+1.6% Hist 90D α
Trajectory: C (59) → C+ (67)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the LFST Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 67/100 (C+) score, LFST faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Company executives have done more routine share selling than personal cash buying lately.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-0.68% YoY Shares) — any gross margin slip below 49.5% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($12.53) or 200D SMA ($9.40) invalidates the momentum regime and cuts Target Base ($13.80) toward Bear Floor ($10.76).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $LFST• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “LFST Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
YES 67%NO 33%Trade / Inspect Odds →
RSI-14 MOMENTUMBULLISH MOMENTUM
62.230 Oversold · 70 Hot
ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)
4.84>3.0 Fortress Safe
PIOTROSKI F-SCOREHIGH QUALITY (7–9)
8 / 99-Pt Accounting
52-WEEK LASER RANGE94% OF RANGE
L: $5$13.26H: $14
1. Money & Cash Health● WEAK
Are profits real cash in the bank?

Weak cash conversion or heavy valuation strain compared to actual cash earned.

Factor Grade: DRQD 10 / 20
2. Big Money & Insiders● NEUTRAL
Are whales & executives buying or selling?

Big funds and company insiders are mostly holding steady without aggressive buying or panic selling.

Factor Grade: CRQD 26 / 40
3. Hidden Risks & Market Weather● ALL CLEAR
SEC fine-print scan & interest-rate fit

Clean SEC fine-print check with low hidden accounting risk and favorable interest-rate weather.

Factor Grade: B+RQD 31 / 40
MULTI-MODEL JEV QUANT JURY DELIBERATION

JEV AI Jury Split (Battleground) on LFST

Cash & Moat Bull AI
ROIC & Free Cash Flow Model
BEARISH (50)

1.2% ROIC with 42.0% gross margin and 2.11% FCF yield.

SEC Forensic Auditor AI
10-K Accruals & Altman-Z Guard
BULLISH (90)

Altman-Z 4.84 and Piotroski 8/9 pass balance-sheet audit.

Whale & Macro Hawk AI
Options Skew, 13F & Fed NetLiq
NEUTRAL (65)

26/40 institutional & smart-money positioning score with 13/20 macro alignment.

Bull Case: Why Buyers Like LFST
  • ✓Big institutional funds and options desks are actively positioning on the bullish side.
  • ✓Clean SEC annual filing review with no major hidden accounting time-bombs.
Bear Case: What Could Go Wrong
  • !Company executives have done more routine share selling than personal cash buying lately.
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk

Scheduled RQD Strong Buys & Whale Accumulation Briefing (LFST Tape Review)

  • ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
  • ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
  • ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) →$100K Arena
LFST // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +82.39%▲ ASCENDING CHANNEL
2026-11-03O $13.63H $13.63L $13.26C $13.26VOL 2.30M
RES: $14.96SUP: $12.06SMA50: $12.53SMA200: $9.40
$14.29$12.08$9.87$7.66$5.44RES $14.96SUP $12.06$13.262026-05-042026-06-172026-08-042026-09-182026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

LFST Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 LFST Butterfly Map → + Track LFST →
Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
48.0%/yr Implied 5Y Growth

vs. +13.9% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on LFST today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for LFST. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for LFST today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (LFST)

Health Care Rank #104 of 1015 ⚔️ OPCH vs LFST Full Matrix →

1. Head-to-Head Health Care Peer Comparison (LFST vs. OPCH, HIMS, CHE, AVAH)

Industry: Medical/Nursing Services (29 Tracked Issuers)

Across 1015 tracked Health Care securities in the Roarable RQD universe, LifeStance Health Group Inc. (LFST) ranks #104 by composite RQD confidence (67/100, grade C+) and #161 by equity capitalization ($5.12B). Within this direct 5-issuer industry benchmark cohort, OPCH leads on earnings valuation at 23.0x trailing P/E, while CHE leads on capital efficiency and profitability with 23.4% ROIC and 32.5% gross margin. CHE currently holds the highest overall quantitative score in the immediate peer group at 83/100 (A-) compared with LFST at 67/100 (C+).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
LFST ACTIVE
LifeStance Health Group Inc.
C+ 67/100 — — 1.2% -1.04% $5.12B Benchmark Subject
OPCH
Option Care Health Inc.
B 74/100 23.0x 19.3% 11.9% -0.44% $4.77B /opch-vs-lfst →
HIMS
Hims & Hers Health Inc.
C- 60/100 53.9x 73.8% 8.4% -8.81% $6.46B /hims-vs-lfst →
CHE
Chemed Corp
A- 83/100 — 32.5% 23.4% +1.40% $6.96B /che-vs-lfst →
AVAH
Aveanna Healthcare Holdings Inc.
C 65/100 — 33.3% 15.7% -0.30% $2.87B /avah-vs-lfst →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001845257 ↗

In its most recent audited fiscal period (FY2025, filed 2025-12-31), LifeStance Health Group Inc. (LFST) reported GAAP revenue of $1.42B (+13.9% vs. FY2024 revenue of $1.25B , and +34.9% cumulative change since FY2023) , GAAP net income of $9.7M, operating cash flow of $146.2M, and free cash flow of $110.0M (+28.4% YoY). On the balance sheet, LFST closed FY2025 with $2.20B in total assets against $265.9M in total debt (Altman Z-Score: 4.84, Piotroski F-Score: 8/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $1.42B $9.7M $146.2M $110.0M $2.20B $265.9M
FY2024 (FY) 2024-12-31 $1.25B -$57.4M $107.3M $85.7M $2.12B $279.8M
FY2023 (FY) 2023-12-31 $1.06B -$186.3M -$16.9M -$16.9M — —

3. LFST Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is LFST stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, LifeStance Health Group Inc. (NASDAQ: LFST) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 67/100 at a spot price of $13.26 (-1.04% 1D, market cap $5.12B). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 16/20, SEC Balance-Sheet Forensics 18/20, FRED Macro Regime Fit 13/20, and Executive Insider Alignment 10/20. Across 1015 tracked Health Care issuers, LFST ranks #104 in composite RQD confidence.

How does LFST compare to OPCH and HIMS in the Health Care sector?

Within the Health Care sector (Medical/Nursing Services), LFST carries a Roarable C+ (67/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of 1.2%. By comparison, OPCH (Option Care Health Inc.) holds a B grade (74/100 RQD, P/E 23.0x, ROIC 11.9%, cap $4.77B) and HIMS (Hims & Hers Health Inc.) posts a C- grade (60/100 RQD, P/E 53.9x, ROIC 8.4%, cap $6.46B). Among the 5-stock peer group, OPCH leads on earnings multiple (23.0x) while CHE leads on capital efficiency (23.4% ROIC).

What are the biggest fundamental strengths and SEC risk factors for LFST?

Per LFST's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001845257), LifeStance Health Group Inc. generated $1.42B in revenue (+13.9% YoY), $9.7M in net income, and $110.0M in free cash flow against $2.20B in total assets and $265.9M in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

Where is LFST trading relative to its 50-day, 200-day, and 52-week technical levels?

LFST last traded at $13.26 (-1.04% on volume of 3,364,949 shares), positioning the stock +5.83% above its 50-day simple moving average ($12.53) and +41.06% above its 200-day simple moving average ($9.40). Across its 52-week range of $4.77 to $13.76, LFST sits at the 94.4% percentile with a 14-day RSI of 62.2 (BULLISH MOMENTUM) and an implied next-earnings move of ±6.8% ($12.36 to $14.16).

Direct Sub-Reports: LFST RQD Cockpit LFST 12M Forecast LFST Earnings & Move LFST Dividends & DRIP LFST Insiders & 13F LFST Whale Options LFST Profit Sankey LFST News & Why
ROARABLE RATING BRIEF • RQD 67/100 (C+) ✓ SEC XBRL & RQD VERIFIED

LFST — LifeStance Health Group Inc.: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

LifeStance Health Group Inc. (LFST) earns a live Roarable RQD composite score of 67/100, corresponding to a C+ letter grade (Roarable Hold) at a spot price of $13.26 (-1.04% 1D, market capitalization $5.12B).

  • Fundamental Cash Engine (10/20): Anchored by return on invested capital (ROIC) of 1.2%, gross margin of —, operating margin of 1.7%, and free cash flow yield of 2.11%.
  • Whale 13F & Options Flow (16/20) + Insider Conviction (10/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (13/20) + Forensic Balance Sheet (18/20): Incorporates a 1.00x equity beta, Altman Z-Score of 4.84, Piotroski F-Score of 8/9, and Debt/Equity of 0.17x.

2. Business Model, Unit Margins & SEC Financial Trajectory

LifeStance Health Group Inc. Is a NASDAQ-listed issuer in the Health Care sector, within the Medical/Nursing Services industry. The company reported FY 2025 revenue of $1.42B.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), LifeStance Health Group Inc. (LFST) reported $1.42B in annual revenue (up from $1.25B in FY2024, +13.9% YoY) and $9.7M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($1.06B revenue, -$186.3M net income) through FY2025, LFST scaled operating cash flow to $146.2M and free cash flow to $110.0M, backed by $2.20B in total assets against $265.9M in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • 🐂 Primary Bull Case (C+ • RQD 67/100): Big institutional funds and options desks are actively positioning on the bullish side. Clean SEC annual filing review with no major hidden accounting time-bombs. With Fundamental Cash Engine at 10/20 and Institutional Whale Flow at 16/20, sustained execution supports upside toward the upper end of the $4.77 – $13.76 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation and 95.3x EV/EBITDA against 1.7% operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Operating in Medical/Nursing Services (Health Care), LFST carries a macro regime beta of 1.00 and gross margin of —.

  • Key Question #1: Can LFST sustain or expand its 1.7% operating margin and 1.2% ROIC against Medical/Nursing Services peers over the next 4 quarters?
  • Key Question #2: Following FY2025 revenue of $1.42B and free cash flow of $110.0M, how will capital allocation balance growth reinvestment against $265.9M in total debt?
  • Key Question #3: How sensitive is LFST's equity valuation to Health Care capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

LFST Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for LifeStance Health Group Inc. (LFST) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to LFST Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

LFST Bull vs. Bear Conversation Board — What's Your Call at $13.26?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON LFST 🐻 33% BEARISH CONVICTION
1. Pick Your Side on LFST:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
MA MacroHawk_NYC RQD DEBATE OPENER • Cross-Asset Macro Desk 🐂 BULLISH 🎯 Target: $17.02 (+27.0%)
📌 Pinned Debate

Balance-sheet strength (Altman Z 4.84, Piotroski F 8/9, Debt/Equity 0.17) and 17 of 20 institutional-flow score support the rating.

Balance-sheet strength (Altman Z 4.84, Piotroski F 8/9, Debt/Equity 0.17) and 17 of 20 institutional-flow score support the rating.. When you look under the hood at LFST, Fundamental Cash Engine is 10/20 with 0.0% gross margins and 1.2% ROIC. Bears are staring in the rearview mirror while institutional 13F flow (16/20) has been quietly accumulating below $13.76. My 12M target is $17.02.

RetailWhale_TX 🐂 BULL

Both sides have a point here — LFST's 18/20 balance sheet score keeps downside contained, so the real swing factor next earnings call is backlog and FCF conversion.

ME MeanReversion_88 RQD DEBATE OPENER • Quantitative Statistical Arb 🐻 BEARISH 🎯 Target: $11.39 (-15.0%)
Spot @ $13.40

ROIC of 1.2% and a 95.3 EV/EBITDA multiple leave thin returns against a premium valuation.

ROIC of 1.2% and a 95.3 EV/EBITDA multiple leave thin returns against a premium valuation.. Look at the math on LFST: paying current EV/EBITDA multiples for 1.2% ROIC and 1.7% operating margins leaves zero margin of safety if Medical/Nursing Services demand softens. I'd wait for a retest of $11.79 before getting long.

LIVE TAPE SPY $752.10 -1.80% QQQ $681.09 -3.60% DIA $519.34 -1.08% IWM $279.14 -1.68% NVDA $202.06 -1.26% AAPL $338.32 -1.83% MSFT $507.12 -2.83% TSLA $403.82 +1.00% PLTR $178.34 -3.13% SOFI $16.60 -0.95% IBIT $43.35 -5.42% GLD $361.65 -3.59%